<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">safetyrisk</journal-id><journal-title-group><journal-title xml:lang="ru">Безопасность и риск фармакотерапии</journal-title><trans-title-group xml:lang="en"><trans-title>Safety and Risk of Pharmacotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2312-7821</issn><issn pub-type="epub">2619-1164</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">safetyrisk-33</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Совершенствование принципов управления сигналами по безопасности лекарственных препаратов для медицинского применения</article-title><trans-title-group xml:lang="en"><trans-title>Perfection of management principles by the safety signals of medicinal products</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романов</surname><given-names>Б. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanov</surname><given-names>B. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лепахин</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Lepakhin</surname><given-names>V. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>E. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Астахова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Astakhova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глаголев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Glagolev</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поливанов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Polivanov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр экспертизы средств медицинского применения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Expert Evaluation of Medicinal Products</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский университет дружбы народов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральная служба по надзору в сфере здравоохранения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Roszdravnadzor of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Центр по мониторингу эффективного, безопасного и рационального использования лекарственных средств Росздравнадзора</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center for Monitoring of Effective, Safety and Rational Use of Medicinal Products, Roszdravnadzor of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2018</year></pub-date><volume>0</volume><issue>1</issue><fpage>10</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Романов Б.К., Лепахин В.К., Журавлева Е.О., Астахова А.В., Глаголев С.В., Поливанов В.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Романов Б.К., Лепахин В.К., Журавлева Е.О., Астахова А.В., Глаголев С.В., Поливанов В.А.</copyright-holder><copyright-holder xml:lang="en">Romanov B.K., Lepakhin V.K., Zhuravleva E.O., Astakhova A.V., Glagolev S.V., Polivanov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.risksafety.ru/jour/article/view/33">https://www.risksafety.ru/jour/article/view/33</self-uri><abstract><p>Представлена системная оценка принципов управления сигналами по безопасности лекарственных препаратов для медицинского применения. Рассмотрены источники получения сигналов, подходы к обнаружению сигналов, процессы обработки и выявления, валидации, анализа и приоритизации, оценки сигналов. Дан обзор индивидуальных отчетов о безопасности. Показан статистический анализ в больших базах данных и процессы регулирования. Даны практические рекомендации по выявлению сигналов в национальных и международных базах данных.</p></abstract><trans-abstract xml:lang="en"><p>Systematic evaluation of management principles by signals on medicinal drugs safety is submitted. The sources of signals, the approaches to the detection signal processing and detection, validation, analysis and prioritization, signal assessment are considered. A review of the individual security reports is demonstrated. A statistical analysis of large databases and processes of their regulation was shown. Practical recommendations for the identification of signals in national and international databases are given.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>управление</kwd><kwd>сигнал</kwd><kwd>безопасность</kwd><kwd>лекарственное средство</kwd><kwd>лекарственный препарат</kwd><kwd>фармаконадзор</kwd><kwd>signal management</kwd><kwd>management</kwd><kwd>signal</kwd><kwd>safety</kwd><kwd>drug</kwd><kwd>medicinal products</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Лепахин ВК, Романов БК, Торопова ИА. Анализ сообщений о нежелательных реакциях на лекарственные средства. Ведомости Научного центра экспертизы средств медицинского применения. 2012. № 1. С. 22-25.</mixed-citation><mixed-citation xml:lang="en">Lepakhin VK, Romanov BK, Toropova IÀ. Analysis of reports of adverse reactions to  drugs. Scientific centre of expert evaluation of medicinal product bulletin. 2012;  (1): 22–25 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Меркулов ВА, Бунятян НД, Сакаева ИВ, Лепахин ВК, Романов БК, Ефремова ТА. Новые законодательные инициативы по повышению безопасности лекарственных средств в европейском союзе. Ведомости Научного центра экспертизы средств медицинского применения. 2013. № 3. С. 45-48.</mixed-citation><mixed-citation xml:lang="en">Merkulov VÀ, Bunyatyan ND, Sakaeva IV, Lepakhin VK, Romanov BK, Efremova TÀ. New  legislation initiatives to improve drug safety in European Union. Scientific centre of  expert evaluation of medicinal product bulletin. 2013; (3): 45–48 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Guideline on Good pharmacovigilance practices [Электронный ресурс]: http://www.ema.europa.eu/ ema/index.jsp?curl=pages/regulation/document_listing/ document_listing_000345.jsp&amp;mid=WC0b01ac058058f32c#section1 (дата обращения: 25.12.2015).</mixed-citation><mixed-citation xml:lang="en">Guideline on Good pharmacovigilance practices [Electronic resource].—Available  from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp&amp;mid=WC0b01ac058058f32csection1(cited 2015 Dec 25).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Правила надлежащей практики фармаконадзора [Электронный ресурс]: http://www.eurasiancommission.org/ru/act/texnreg/deptexreg/konsultComitet/ Documents82.pdf (дата обращения: 25.12.2015).</mixed-citation><mixed-citation xml:lang="en">Good Pharmacovigilance practice (GVP) [Electronic resource]. — Available from:  http://www.eurasiancommission.org/ru/act/texnreg/deptexreg/konsult-Comitet/Documents82.pdf (cited 2015 Dec 25) (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Информационный справочник понятий (терминов) [Электронный ресурс]: http://www.eurasiancommission.org/ru/act/texnreg/deptexreg/konsultComitet/ Pages.b2.aspx (дата обращения: 25.12.2015).</mixed-citation><mixed-citation xml:lang="en">Good Pharmacovigilance practice (GVP) [Electronic resource]: — Available from:  http://www.eurasiancommission.org/ru/act/texnreg/deptexreg/konsult-Comitet/Pages.b2.aspx (cited 2015 Dec 25) (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по экспертизе лекарственных средств. Т. III. - М.: ПОЛИГРАФ-ПЛЮС, 2014 - 344 с.</mixed-citation><mixed-citation xml:lang="en">The guidelines for the examination of medicinal products. V. III. — M.: POLYGRAPH- PLUS, 2014. 344 p. (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
